Biomilab LLC

Lansing, MI

UEI
HRZKLBDZQYA7
CAGE
800M2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4209 S Pennsylvania Ave, Lansing, MI 48910, USA
Website
biomilab.com
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Consulting
SIC code
89 Services, Not Elsewhere Classified

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $1,586,107

Contract awards

Grant awards

Similar vendors

About the company

Biomilab LLC, a for-profit Subchapter S corporation based in Lansing, Michigan, develops biological agents to control invasive dreissenid mussels in North American waterways as a prime contractor and grant recipient across three federal agencies, operating entirely outside set-aside categories on a small federal footprint.

Biomilab's core capability centers on genetic engineering and cell biology applied to invasive species eradication. The vendor's approach uses engineered mussel cancer cells (transformed cell lines carrying oncogenes) that reproduce a natural pathogenic mechanism called disseminated neoplasia, designed to target zebra and quagga mussels without harming native aquatic ecosystems or non-target species. Recent work includes a $1.586 million firm fixed-price definitive contract awarded by the U.S. Army Corps of Engineers in September 2024 for research and development of a biological agent to safely eradicate invasive mussels in open waters, with completion targeted for September 2026. The vendor holds two federal grants from the Department of the Interior: a $567,730 Cooperative Agreement from the Bureau of Reclamation under the SECURE Water Act Research Agreements program (CFDA 15.560), awarded February 2026 with completion targeted for June 2029, covering continued methodological refinement for oncogene delivery via microinjection, cryopreservation protocols for mussel cells and embryos, and optimization of mussel embryo cultivation techniques; and a prior Project Grant from the Fish and Wildlife Service Region 2, awarded September 2023 with completion in December 2024, focused on developing transformed cell lines from invasive dreissenids.

The vendor's customer base divides evenly among the Army Corps of Engineers, the Bureau of Reclamation, and the Fish and Wildlife Service. Four awards across seven years (one each in 2019, 2023, and 2024, and one in 2026) account for $1.6 million in combined potential value, though obligated dollars total $3.8 million. One award—the Army Corps contract—reaches ultimate completion within the next twenty-four months and therefore faces recompete. Biomilab operates as a 100% prime footprint with no subcontract engagements in the source data. The vendor competes full-and-open, without set-aside designations across its recent portfolio.

Quick answers

Is Biomilab LLC registered in SAM.gov?

Yes. Biomilab LLC's SAM.gov registration is active through April 6, 2027.

How much has Biomilab LLC received in federal contracts?

Federal contracts obligated $1,586,107 to Biomilab LLC in fiscal years 2023 through 2027.

What is Biomilab LLC's most recent federal award?

Biomilab LLC's most recent federal grant award is IT is generally accepted that once dreissenid mussels are established in a large waterway, eradication is neither… (R25AC00552), from Bureau of Reclamation, on February 17, 2026.

On GovTribe

See Biomilab LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors